我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

骨髓间充质干细胞移植显著促进急性心肌梗死大鼠的心功能恢复 (PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2008年第3期
页码:
273-278
栏目:
基础研究
出版日期:
2008-05-20

文章信息/Info

Title:
Transplantation of BMMSCs leads to significant cardiac improvement in AMI rat model
作者:
林强陈书艳李月华李毅刚王长谦许勤王飞周卿
上海交通大学医学院附属新华医院心内科,上海 200092
Author(s):
LIN Qiang CHEN Shuyan LI Yuehua LI Yigang WANG Changqian XU Qin WANG Fei ZHOU Qing
Department of Cardiology, Xinhua Hospital of Medical College, Shanghai Jiaotong University, Shanghai 200092, China
关键词:
心肌梗死细胞移植心肌细胞骨髓细胞大鼠
Keywords:
myocardial infarction cellular cardiomyoplasty myocardial cells bone marrow cells rat
分类号:
R542.2
DOI:
-
文献标识码:
A
摘要:
目的 通过横向比较乳鼠心肌细胞、骨髓单个核细胞(BMMNCs)、骨髓间充质干细胞(BMMSCs)移植治疗大鼠急性心肌梗死(MI)的疗效,确定更优异的移植细胞。 方法 以结扎法建立大鼠急性MI模型,分离培养乳鼠心肌细胞、BMMNCs、BMMSCs,体外进行DAPI标记后,直视下分别植入急性MI1周后的大鼠MI中心及边缘区,移植的细胞数为2×106/只。移植后4周,进行后心功能检测,并处死动物以免疫组化染色法检测移植细胞的分化及血管新生。 结果 LSD法检测显示,大鼠的左室射血分数(LVEF), BMMSCs移植组为(61.00±2.21)%、乳鼠心肌细胞移植组为(58.74±2.21)%、BMMNCs移植组为(59.87±3.05)%较对照组[为(55.45±3.05)%]大鼠的心功能均有显著提高(P值依次为<0.05、<0.05、<0.01)其中BMMSCs组优于其他处理组,BMMSCs能表达血管平滑肌肌动蛋白,促进血管新生,但未见其表达心肌细胞的特异抗原。 结论 在分别以乳鼠心肌细胞、BMMNCs和BMMSCs移植治疗大鼠的急性MI的比较中,BMMSCs对心功能的保护效果最显著,保护机制与其血管新生等有关。
Abstract:
AIM To assess the therapeutic effect of different cells in myocardial infarction treatment. METHODS By ligation, we made the acute myocardial infarction AMI rat model, isolated and cultured bone marrow mononuclear cells (BMMNCs), bone marrow mesenchymal stem cells(BMMSCs) and neonatal cardiomyocytes, and labeled them with DAPI before injecting the same mount of cells (2×106 each) into center and skirt areas of scars of a oneweekold myocardial infarction in SD rats. Four weeks after transplantation, the presence and differentiation of engrafted cells, neovascularization and their effect on LV ejection fraction were studied. RESULTS The LVEF in BMMSCs [(61.00±2.21)%], BMMNCs [(59.87±3.05)%], natal myocardial cellstreated [(58.74±2.21)%] groups significantly increased (P<0.05, P<0.05, P<0.01, respectively) than the LVEF in PBS group [(5545±305)%]. The effect of BMMSCstreated group was most obvious. BMMSCs expressed αSMA and promoted neovascularization, but no expression of cardiac specific antigen was found in BMMSCs. CONCLUSIONS Of the 3 kinds of cells, BMMSCs are most effective in the treatment of myocardial infarction, which may come from the neovascularization, protection and antiapoptosis of myocardial cells.

参考文献/References

[1] Tremain N, Korkko J, Ibberson D, et al. MicroSAGE analysis of 2,353 expressed genes in a single cellderived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages[J]. Stem Cells, 2001, 19(5):408-418.

[2] Kashiwakura Y, Katoh Y, Tamayose K, et al. Isolation of bone marrow stromal cellderived smooth muscle cells by a human SM22alpha promoter: in vitro differentiation of putative smooth muscle progenitor cells of bone marrow[J]. Circulation, 2003, 107(16):2078-2088.

[3] Reyes M, Dudek A, Jahagirdar B, et al. Origin of endothelial progenitors in human postnatal bone marrow[J]. J Clin Invest, 2002, 109(3):337-346.

[4] Kinnaird T, Stabile E, Burnett MS, et al. Marrowderived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms[J]. Circ Res, 2004, 94(5):678-685.

[5] Schuster MD, Kocher AA, Seki T, et al. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration[J]. Am J Physiol Heart Circ Physiol, 2004, 287(2):H525-H532.

[6] Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics[J]. Circ Res, 2004, 95(1):9-20.

[7] Abbate A, BiondiZoccai GG, Baldi A, et al. Pathophysiologic role of myocardial apoptosis in postinfarction left ventricular remodeling[J]. J Cell Physiol, 2002, 193(2):145-153

.[8] Dai W, Hale SL, Martin BJ, et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short and longterm effects[J]. Circulation, 2005, 112(2):214-223.

[9] Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro[J]. J Clin Invest, 1999, 103(5):697-705.

备注/Memo

备注/Memo:
收稿日期:2007-03-16.基金项目:国家自然科学基金项目资助 (30270534) 通讯作者:陈书艳,教授,主要从事干细胞移植治疗缺血性心肌病的研究Email:shuyanchencn@yahoo.com.cn 作者简介:林强,住院医生,硕士生Email:dawnblack@sina.com
更新日期/Last Update: